I think the short answer is yes, and I think that is true for the U.S. as well.
Innovation has been moving to other jurisdictions, where it exists at all. China is becoming ever more active in research and development in antimicrobials as well as the manufacture of drugs. That is the challenge we see with some frequency in shortages around the world for antibiotics, due to a number of factors. It could be a storm that damages a factory in the U.S., Europe or Canada, and that may be one of two factories that produce this drug for the world. If we damage one, the supply chain is fractured, and it can take months or years to rebuild that.
We've seen that with shortages, and I think we see that with branded pharmaceuticals as well, particularly in the anti-infective space.